Galantamine supplementation and rheumatoid arthritis: a systematic review of current research and molecular mechanisms. | Synapse
February 27, 2026
Galantamine supplementation and rheumatoid arthritis: a systematic review of current research and molecular mechanisms.
Puntos clave
This review aims to evaluate the therapeutic effects of galantamine in rheumatoid arthritis and identify molecular mechanisms involved.
Conducted a systematic review of existing research on galantamine and rheumatoid arthritis.
Analyzed both preclinical and clinical studies.
Identified and summarized molecular mechanisms related to galantamine's effects.
Highlighted galantamine's potential as a therapeutic agent in rheumatoid arthritis.
Emphasized the necessity for further translational research to apply findings clinically.
Resumen
This review emphasizes GAL's therapeutic potential as well as the critical need for translational research to bridge the gap between preclinical and clinical applications.